[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355739-105":59,"doc-detail-355739-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","integrated-analysis-of-the-prognostic-and-immunotherapeutic-significance-of-zeb1-as1-in-hepatocellular-carcinoma","Integrated analysis of the prognostic and immunotherapeutic significance of ZEB1-AS1 in hepatocellular carcinoma","","Integrated analysis combining bioinformatic inference and in vitro validation evaluates how ZEB1-AS1 relates to prognosis and immunotherapy relevance in hepatocellular carcinoma (HCC). HCC datasets from The Cancer Genome Atlas (TCGA) are analyzed using univariate and multivariate Cox regression, alongside co-expression and functional enrichment in R. Cell-based assays quantify ZEB1-AS1 and test effects on proliferation, migration, and invasion. Results indicate ZEB1-AS1 overexpression predicts poor outcomes and aligns with altered immune/stromal scores, immune cell infiltration, checkpoint activity, therapy response, and drug sensitivity, suggesting a prognostic indicator and immune-related target for HCC management.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-analysis-of-the-prognostic-and-immunotherapeutic-significance-of-zeb1-as1-in-hepatocellular-carcinoma/355739/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-analysis-of-the-prognostic-and-immunotherapeutic-significance-of-zeb1-as1-in-hepatocellular-carcinoma/355739.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of analyzing ZEB1-AS1 in HCC?","Question",{"text":112,"@type":113},"To explore whether ZEB1-AS1 has prognostic value and immune relevance in hepatocellular carcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prognostic value of ZEB1-AS1 evaluated?",{"text":117,"@type":113},"HCC-related datasets from TCGA were analyzed using univariate and multivariate Cox regression to assess prognostic associations.",{"name":119,"@type":110,"acceptedAnswer":120},"What did in vitro experiments show about ZEB1-AS1 in HCC cells?",{"text":121,"@type":113},"ZEB1-AS1 knockdown markedly inhibited Huh-7 cell proliferation and reduced migratory and invasive capacities.",{"name":123,"@type":110,"acceptedAnswer":124},"How is ZEB1-AS1 linked to tumor immunity and treatment response?",{"text":125,"@type":113},"ZEB1-AS1 expression showed associations with stromal/immune scores, multiple immune cells, immune checkpoint inhibitor activity, immunotherapy response, and drug sensitivity.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},355739,1790211548,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":36,"preview_page_count":19,"preview_urls":149},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Original Article  \nIntegrated analysis of the prognostic and immunotherapeutic significance of ZEB1-AS1 in hepatocellular carcinoma  \nXiangdong Niu1,2,3\\#, Yifeng Chen1,3\\#, Jing Yu1,2, Xue Chen1, Xuyun Wang1, Guogan Ding1, Liangyin Fu1, Xiangyong Hao1,3  \n1Department of General Surgery, Gansu Provincial Hospital, Lanzhou, China; 2The First Clinical Medical College of Lanzhou University, Lanzhou, China; 3Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Lanzhou, China Contributions: (I) Conception and design: Hao X, Niu X; (II) Administrative support: Chen Y; (III) Provision of study materials or patients: Yu J, Chen X;  \n(IV) Collection and assembly of data: Wang X, Ding G; (V) Data analysis and interpretation: Fu L, Niu X; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Xiangyong Hao, PhD. Department of General Surgery, Gansu Provincial Hospital, 204 Donggang West Road, Lanzhou 730000, China; Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Lanzhou, China. [Email: haoxy-2008@163.com](Email: haoxy-2008@163.com).  \nBackground: Zinc finger E-box binding homeobox 1 antisense 1 (ZEB1-AS1) is a long non-coding RNA (lncRNA) related to the progression of several malignancies and a regulator of oncogenesis in several cancers.  \nTherefore, the aim of our study was to explore the prognostic value and immune relevance of ZEB1-AS1 in  \nhepatocellular carcinoma (HCC) .  \nMethods: In this study, a comprehensive investigation integrating bioinformatic analysis and in vitro experiments was conducted to evaluate the role of ZEB1-AS1 in HCC. HCC-related datasets were retrieved from The Cancer Genome Atlas (TCGA) database to analyze the prognostic value of ZEB1-AS1 via univariate and multivariate Cox regression. The potential biological functions and immune-related correlations of ZEB1-AS1 were explored through co-expression analysis and functional enrichment using R software (v4.0.5) . Furthermore, in vitro assays were performed, including quantitative real-time polymerase chain reaction (qRT-PCR) to quantify ZEB1-AS1 expression in HCC and normal liver cells, as well as  \nfunctional experiments to assess its impact on cell proliferation and motility.  \nResults: ZEB1-AS1 overexpression was associated with poor prognosis in HCC patients. ZEB1-AS1 expression and tumor stage were independent prognostic factors in patients with HCC. The expression of ZEB1-AS1 was significantly increased in HCC cell lines. Functional assays revealed that knockdown of ZEB1-AS1 markedly inhibited Huh-7 cell proliferation and suppressed their migratory and invasive capacities. A significant negative association of ZEB1-AS1 expression with stromal score and immune score was observed. ZEB1-AS1 expression was correlated with multiple immune cells, immune checkpoint inhibitor, immunotherapy response and drug sensitivity. ZEB1-AS1 was involved in the regulation of tumor  \nassociated signaling pathways.  \nConclusions: In conclusion, our integrated bioinformatic analysis and in vitro validation suggest that ZEB1-AS1 may serve as a potential theoretical prognostic indicator and a target for immune checkpoint reactivity in HCC. These findings provide a novel direction and a theoretical framework for future research  \ninvolving large-scale clinical cohorts to confirm its clinical application in the long term.  \nKeywords: Zinc finger E-box binding homeobox 1 antisense 1 (ZEB1-AS1); hepatocellular carcinoma (HCC);  \nprognostic; immune; The Cancer Genome Atlas (TCGA)  \nSubmitted Nov 06, 2025. Accepted for publication Feb 09, 2026. Published online Mar 25, 2026.  \ndoi: 10.21037/tcr-2025-aw-2446  \nView this article at: [https://dx.doi.org/10.21037/tcr-2025-aw-2446](https://dx.doi.org/10.21037/tcr-2025-aw-2446)  \n© AME Publishing Company. Transl Cancer Res 2026;15(4):","cbCaic2tGe6e9Iji","https://ap.wps.com/l/cbCaic2tGe6e9Iji","pdf",4478432,16,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the main purpose of analyzing ZEB1-AS1 in HCC?\",\"answer\":\"To explore whether ZEB1-AS1 has prognostic value and immune relevance in hepatocellular carcinoma.\"},{\"question\":\"How was the prognostic value of ZEB1-AS1 evaluated?\",\"answer\":\"HCC-related datasets from TCGA were analyzed using univariate and multivariate Cox regression to assess prognostic associations.\"},{\"question\":\"What did in vitro experiments show about ZEB1-AS1 in HCC cells?\",\"answer\":\"ZEB1-AS1 knockdown markedly inhibited Huh-7 cell proliferation and reduced migratory and invasive capacities.\"},{\"question\":\"How is ZEB1-AS1 linked to tumor immunity and treatment response?\",\"answer\":\"ZEB1-AS1 expression showed associations with stromal/immune scores, multiple immune cells, immune checkpoint inhibitor activity, immunotherapy response, and drug sensitivity.\"}]","Integrated analysis of the prognostic and immunotherapeutic significance of ZEB1-AS1 in hepatocellular carcinoma | PDF",1790120713,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60798e54c183f3f28451c29b5e821a7d.webp",983,1287,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22abfa58dfcbaf70992fb0ee88560e71.webp",982,1286,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db9b52fef327c775b29e7e926de3dd06.webp",981,1284,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e79df45050157774b748f5ce6b7d5f78.webp",980,1283]